Skip to main content
. 2019 Feb 5;48(2):82–89. doi: 10.1111/jmp.12399

Table 2.

Frequency of T cells from bronchoalveolar lavage cells producing cytokines during Mycobacterium tuberculosis infection in non‐human primates (n = 28). CD4, CD4CD8, and CD8 T cells within the T cell gate (CD3+) are shown in the top row

BAL Weeks post‐Mtb infection CD4 CD4CD8 CD8 P value (CD4 vs CD4CD8) P value (CD8 vs CD4CD8)
Median [25%, 75%] Median [25%, 75%] Median [25%, 75%]
T cell % 0 36.8 [31.4‐45.6] 4.0 [2.5‐6.2] 39.7 [31.3‐46.1] <0.0001 <0.0001
4 wk 30.5 [22.4‐42.0] 8.0 [4.1‐15.3] 42 [40.5‐49.6] <0.0001 <0.0001
12 wk 37.4 [23.0‐45.2] 3.9 [2.5‐12.6] 44.6 [39.9‐52.5] <0.0001 <0.0001
Dx 33.4 [26.6‐44.3] 2.9 [1.2‐9.2] 50.2 [40.8‐56.6] <0.0001 <0.0001
IFN‐γ % 0 0.75 [0.4‐2.2] 6.5 [0.6‐16.0] 2.1 [0.7‐5.5] 0.0027 0.0232
4 wk 2.9 [1.1‐9.4] 5.3 [2.8‐9.6] 1.4 [0.5‐2.5] 0.0753 <0.0001
12 wk 2.9 [0.98‐6.3] 3.4 [1.4‐5.6] 0.85 [0.5‐2.2] 0.0001
Dx 1.45 [0.5‐4.1] 1.2 [0.3‐2.8] 0.3 [0.1‐0.6] 0.0126
IL‐10% 0 2.3 [0.9‐7.3] 8.1 [3.3‐13.6] 2.5 [1.1‐3.7] 0.0192 0.0020
4 wk 1 [0.2‐3.7] 6.1 [2.2‐13.2] 1.1 [0.38‐4.3] 0.0284 0.0365
12 wk 1.9 [0.6‐5.4] 9.7 [4.9‐19.2] 2.4 [0.5‐13.6] 0.0015
Dx 0.66 [0.2‐3.2] 7.1 [0‐13.6] 1.7 [0.05‐6.5]
IL‐17% 0 1.4 [0.7‐3.1] 5.6 [2.6‐14.6] 1.25 [0.6‐2.6] <0.0001 <0.0001
4 wk 2.4 [1.2‐7.9] 5.3 [2.4‐10.4] 0.95 [0.5‐3.7] 0.0464 0.0016
12 wk 0.8 [0.3‐2.6] 2.8 [1.6‐7.7] 0.3 [0.1‐0.58] 0.0008 <0.0001
Dx 0.34 [0‐1.9] 4.76 [1.7‐9.9] 0.35 [0.1‐0.65] <0.0001 <0.0001
IL‐2% 0 1.3 [0.8‐5.5] 5.1 [2.3‐9.6] 1.3 [0.8‐2.6] 0.0046 0.0001
4 wk 3.6 [1.5‐5.2] 4.7 [3.3‐7.0] 1.6 [0.9‐2.1] 0.0003
12 wk 2.3 [1.4‐3.4] 3.4 [2.4‐5.1] 0.8 [0.5‐1.7] 0.0460 <0.0001
Dx 2.1 [1.0‐3.2] 2.4 [0.9‐5.8] 1.1 [0.2‐1.7] 0.0236
TNF % 0 1.5 [0.9‐4] 6.5 [1.6‐10.7] 2.8 [1.5‐7.8] <0.0051
4 wk 6.8 [3‐12.3] 10.0 [4.1‐19.4] 2.6 [0.9‐9.2] 0.0018
12 wk 5.1 [2.5‐8.1] 5.2 [3.2‐7.4] 2 [1.0‐3.0] 0.0001
Dx 1.8 [0.2‐5.2] 0.76 [0.4‐5.3] 1.2 [0.2‐3.2]

Percentages of cells expressing each cytokine are represented for CD4, CD4CD8, or CD8 T cells from cells stimulated with ESAT6/CFP10. Analysis performed on each pair of cell types at each time point using the Wilcoxon method (unadjusted P‐values shown in last column).

Dx, time that clinical outcome is declared (active disease or latent infection); Wk, weeks post‐infection.

Significance is P ≤ 0.05.